Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation.

Cell Reports
Xuan HuangClifford J Woolf

Abstract

Drug development is hampered by poor target selection. Phenotypic screens using neurons differentiated from patient stem cells offer the possibility to validate known and discover novel disease targets in an unbiased fashion. To identify targets for managing hyperexcitability, a pathological feature of amyotrophic lateral sclerosis (ALS), we design a multi-step screening funnel using patient-derived motor neurons. High-content live cell imaging is used to evaluate neuronal excitability, and from a screen against a chemogenomic library of 2,899 target-annotated compounds, 67 reduce the hyperexcitability of ALS motor neurons carrying the SOD1(A4V) mutation, without cytotoxicity. Bioinformatic deconvolution identifies 13 targets that modulate motor neuron excitability, including two known ALS excitability modulators, AMPA receptors and Kv7.2/3 ion channels, constituting target validation. We also identify D2 dopamine receptors as modulators of ALS motor neuron excitability. This screen demonstrates the power of human disease cell-based phenotypic screens for identifying clinically relevant targets for neurological disorders.

References

Oct 23, 2002·Journal of Neuroscience Research·Takeshi KiharaAkinori Akaike
Jan 31, 2006·Trends in Neurosciences·Yuri Bozzi, Emiliana Borrelli
Jun 13, 2006·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Miho NakataHugh Bostock
May 24, 2008·Science·Yasemin SancakDavid M Sabatini
Oct 24, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Brigitte van ZundertMark C Bellingham
Apr 7, 2010·Annual Review of Neuroscience·Kevin C KanningChristopher E Henderson
Feb 10, 2011·Pharmacological Reviews·Jean-Martin Beaulieu, Raul R Gainetdinov
Aug 9, 2011·Annual Review of Pharmacology and Toxicology·Feng CongShih-Min A Huang
Nov 22, 2011·Frontiers in Molecular Neuroscience·John H Weiss
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Bilada BilicanSiddharthan Chandran
May 9, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Kazuaki KanaiSatoshi Kuwabara
Oct 23, 2012·Neuron·Qian ChenGuoping Feng
Mar 7, 2013·Nature Reviews. Neuroscience·Wim Robberecht, Thomas Philips
Jul 23, 2013·Nature·Tsai-Wen ChenDouglas S Kim
Oct 22, 2013·Neuron·Christopher J DonnellyJeffrey D Rothstein
Jan 22, 2014·The Journal of Physiology·Nicolas DelestréeDaniel Zytnicki
Jun 26, 2015·Science Translational Medicine·Fabien VincentMarie-Claire Peakman
Nov 20, 2015·Experimental Neurology·Anna E KingJames C Vickers
Jul 13, 2016·Neurology·Kazumoto ShibuyaMatthew C Kiernan
Sep 21, 2016·Cellular and Molecular Life Sciences : CMLS·Derek L Greene, Naoto Hoshi
Oct 28, 2016·Nature Reviews. Neurology·Nimeshan GeevasingaSteve Vucic
Nov 24, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Susanna B ParkSteve Vucic
Jan 21, 2017·Nature Reviews. Drug Discovery·Lyn H Jones, Mark E Bunnage
May 26, 2017·Science Translational Medicine·Keiko ImamuraHaruhisa Inoue
Aug 20, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Juhyun KimSolange P Brown
May 23, 2018·International Journal of Molecular Sciences·Dongmei WangXin Zhang

❮ Previous
Next ❯

Citations

Aug 8, 2021·International Journal of Molecular Sciences·Dorit TrudlerStuart A Lipton
Aug 9, 2021·Trends in Biotechnology·Adam M BeitzKate E Galloway
Nov 11, 2021·Science Translational Medicine·Selwyn JayakarClifford J Woolf

❮ Previous
Next ❯

Software Mentioned

CHEMBL
pCLAMP
NIS
Arrayscan
ElementsAR

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.